Back to VRTX
KBC Group NV VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
18
Latest value
$327K
Q3 2026
Peak value
$64.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.8M |
| Q3 2025 | $48.4M |
| Q3 2025 | $46K |
| Q3 2025 | $137K |
| Q4 2025 | $4.3M |
| Q4 2025 | $59.4M |
| Q4 2025 | $37K |
| Q4 2025 | $283K |
| Q1 2026 | $4.3M |
| Q1 2026 | $52.4M |
| Q1 2026 | $22K |
| Q1 2026 | $162K |
| Q2 2026 | $4.8M |
| Q2 2026 | $58.7M |
| Q2 2026 | $313K |
| Q3 2026 | $5M |
| Q3 2026 | $64.6M |
| Q3 2026 | $327K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $327K | 626 | — | — |
| Q3 2026 | $64.6M | 123.6K | — | — |
| Q3 2026 | $5M | 9.6K | — | — |
| Q2 2026 | $313K | 630 | — | — |
| Q2 2026 | $58.7M | 118.3K | — | — |
| Q2 2026 | $4.8M | 9.6K | — | — |
| Q1 2026 | $162K | 363 | — | — |
| Q1 2026 | $22K | 1.9K | — | — |
| Q1 2026 | $52.4M | 117.3K | — | — |
| Q1 2026 | $4.3M | 9.6K | — | — |
| Q4 2025 | $283K | 624 | — | — |
| Q4 2025 | $37K | 1.9K | — | — |
| Q4 2025 | $59.4M | 130.9K | — | — |
| Q4 2025 | $4.3M | 9.6K | — | — |
| Q3 2025 | $137K | 349 | — | — |
| Q3 2025 | $46K | 1.9K | — | — |
| Q3 2025 | $48.4M | 123.7K | — | — |
| Q3 2025 | $3.8M | 9.6K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B